Resveratrol: Molecular Mechanisms, Health Benefits, and Potential Adverse Effects

IF 10.7 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
MedComm Pub Date : 2025-06-11 DOI:10.1002/mco2.70252
Zhuo-qun Ren, Sheng-yuan Zheng, Zhengcheng Sun, Yan Luo, Yu-tong Wang, Ping Yi, Yu-sheng Li, Cheng Huang, Wen-feng Xiao
{"title":"Resveratrol: Molecular Mechanisms, Health Benefits, and Potential Adverse Effects","authors":"Zhuo-qun Ren,&nbsp;Sheng-yuan Zheng,&nbsp;Zhengcheng Sun,&nbsp;Yan Luo,&nbsp;Yu-tong Wang,&nbsp;Ping Yi,&nbsp;Yu-sheng Li,&nbsp;Cheng Huang,&nbsp;Wen-feng Xiao","doi":"10.1002/mco2.70252","DOIUrl":null,"url":null,"abstract":"<p>Resveratrol (RES), a naturally occurring polyphenolic compound, has garnered significant attention due to its diverse biological activities, which include anti-inflammatory, antioxidant, and antiaging properties. This review synthesizes current evidence concerning the molecular mechanisms, therapeutic efficacy, and safety profile of RES across a variety of pathologies, with an emphasis on the latest research conducted in recent years. Mechanistically, RES is known to modulate critical signaling pathways such as the activation of sirtuin 1. These actions collectively contribute to the attenuation of oxidative stress, regulation of apoptosis, and promotion of autophagy. Preclinical studies have demonstrated the potential of RES in the mitigation of degenerative musculoskeletal disorders, cardiovascular diseases, cancer progression, and neurological diseases. Given the low bioavailability of RES and the potential for adverse reactions in clinical applications, we summarize and discuss its safety profile while outlining future research directions. This review underscores the therapeutic versatility of RES while advocating for rigorous pharmacokinetic optimization, standardized dosing protocols, and large-scale randomized controlled trials to validate its efficacy and safety in human populations.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 6","pages":""},"PeriodicalIF":10.7000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70252","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedComm","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mco2.70252","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Resveratrol (RES), a naturally occurring polyphenolic compound, has garnered significant attention due to its diverse biological activities, which include anti-inflammatory, antioxidant, and antiaging properties. This review synthesizes current evidence concerning the molecular mechanisms, therapeutic efficacy, and safety profile of RES across a variety of pathologies, with an emphasis on the latest research conducted in recent years. Mechanistically, RES is known to modulate critical signaling pathways such as the activation of sirtuin 1. These actions collectively contribute to the attenuation of oxidative stress, regulation of apoptosis, and promotion of autophagy. Preclinical studies have demonstrated the potential of RES in the mitigation of degenerative musculoskeletal disorders, cardiovascular diseases, cancer progression, and neurological diseases. Given the low bioavailability of RES and the potential for adverse reactions in clinical applications, we summarize and discuss its safety profile while outlining future research directions. This review underscores the therapeutic versatility of RES while advocating for rigorous pharmacokinetic optimization, standardized dosing protocols, and large-scale randomized controlled trials to validate its efficacy and safety in human populations.

白藜芦醇:分子机制、健康益处和潜在的不良影响
白藜芦醇(Resveratrol, RES)是一种天然存在的多酚类化合物,因其具有抗炎、抗氧化和抗衰老等多种生物活性而备受关注。本文综述了目前关于RES在多种病理中的分子机制、治疗效果和安全性的证据,重点介绍了近年来的最新研究。在机制上,已知RES可以调节关键的信号通路,如sirtuin 1的激活。这些作用共同有助于氧化应激的衰减、细胞凋亡的调节和自噬的促进。临床前研究已经证明了RES在缓解退行性肌肉骨骼疾病、心血管疾病、癌症进展和神经系统疾病方面的潜力。鉴于RES的生物利用度低,在临床应用中可能出现不良反应,我们总结并讨论了其安全性概况,并概述了未来的研究方向。本综述强调了RES的治疗多功能性,同时提倡严格的药代动力学优化、标准化的给药方案和大规模随机对照试验,以验证其在人群中的有效性和安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.70
自引率
0.00%
发文量
0
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信